ALBIREO PHARMA INC ALBO

July 26, 2018 - 2:04pm EST by

member

						2018	2019
Price:		31.77		EPS		0	0
Shares Out. (in M):		12		P/E		0	0
Market Cap (in $M):		395		P/FCF		0	0
Net Debt (in $M):		-193		EBIT		0	0
TEV (in $M):		202		TEV/EBIT		0	0

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

show sort by

You are not eligible to view 1 messages. To gain access to more recent message posts signup free for membership.

4	member 1/10/23 10:16AM Ipsen to acquire Albireo
A good ending to a non-linear path view available tags
2	member 9/08/20 7:02AM Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC
Excellent results. At the current pre market bid of $45, ALBO is valued at $700M mkt cap. I am going to give them credit for an additional $90M in cash for a priority review voucher,... login to read the rest 1 view available tags
1	member 9/07/20 5:59PM Tomorrow is the day
should be some fireworks tomorrow. continue to think Serum Bile Acid reduction will be positive, and optimistic on pruritus. There is a Priority Review Voucher on the table as well. http://ir.albireopharma.com/news-releases/news-release-details/albireo-announce-topline-results-pedfic-1-phase-3-trial <fingers crossed> view available tags

load more messages